Macro environment determinants affecting the availability of artemisinin-based combination therapies in Uganda

被引:0
|
作者
Oluka Nagitta, Pross [1 ]
Mkansi, Marcia [2 ]
机构
[1] Uganda Management Inst, Dept Econ & Managerial Sci, Kampala, Uganda
[2] Univ South Africa, Dept Operat Management, Pretoria, South Africa
关键词
Pharmaceutical supply chain; Political factors; Economic; Social-cultural; Legal; Technology; Developing countries; DEVELOPING-COUNTRIES; MALARIA; HEALTH; PROCUREMENT; MANAGEMENT; MEDICINE;
D O I
10.1108/IJPHM-09-2020-0074
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeArtemisinin-based combination therapies (ACTs) have been developed to treat uncomplicated malaria. However, scanty studies exist to inform the role of macro factors in explaining the nonavailability of ACT in developing countries. Therefore, this paper aims to evaluate the different macro-environment factors affecting the availability of ACTs in the public hospital setting. Design/methodology/approachThis study applied a quantitative methodological approach and structural equation modeling (SEM) to test hypotheses statistically. SEM examines linear causal relationships among variables while accounting for measurement error. Confirmatory factor analysis (CFA) was used to assess model reliability. CFA and SEM were used to determine the shared variance-covariance of variables, define the latent construct and provide a more precise way to account for the error variances associated with the variables, which, if untested, could lead to biased parameter estimates. This was guided by the data collected from 40 general public hospitals with 283 respondents. FindingsThis study's results support a model for promoting social-cultural, technological and legal factors. The availability of ACTs is significantly affected by legal factors. Improving legal aspects by a unit can enhance ACT availability by 0.59. Political factors scored the least, and they do not influence the availability of malaria drugs. Research limitations/implicationsThe design was quantitative and cross-sectional. Future research could be longitudinal with a mixed-method approach and consider other external stakeholders. Practical implicationsReducing the impact of the nonavailability of antimalarial drugs in general public hospitals requires a holistic concerted and coordinated supply chain approach that tackles the political, economic, social-cultural norms, technological and legal factors. Originality/valueThe authors develop and test a model using macro factors: political, economic, social, cultural, technological and legal factors. This model is relevant for many developing countries to supply chain coordination perpetually experiencing medicine shortages.
引用
收藏
页码:97 / 114
页数:18
相关论文
共 50 条
  • [31] Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study
    Bassi, Peter Usman
    Osakwe, Adeline I.
    Isah, Ambrose
    Suku, Comfort
    Kalat, Musa
    Jalo, Iliya
    Wammanda, Robinson Daniel
    Ugochukwu, Chika
    Adesina, Olubukula
    Nyong, Eno Etim
    Osungwu, Frank
    Pal, Shanti
    Nwoasu, Sylvester Chigozie
    Wallberg, Magnus
    Coulter, David
    DRUG SAFETY, 2013, 36 (09) : 747 - 756
  • [32] Policy brief on improving access to artemisinin-based combination therapies for malaria in Cameroon
    Ongolo-Zogo, Pierre
    Bonono, Renee-Cecile
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (02) : 237 - 241
  • [33] Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
    Justin M Cohen
    Inder Singh
    Megan E O'Brien
    Malaria Journal, 7
  • [34] Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children
    Belard, Sabine
    Ramharter, Michael
    Kurth, Florian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (12):
  • [35] ARTEMISININ-BASED COMBINATION THERAPIES (ACTs) AND HERBAL DRUGS CROSSTALK: FACTS AND PERSPECTIVES
    Randrianarivelojosia, M.
    Randriasamimanana, J. R.
    Martin, C.
    PARASITE, 2009, 16 (03) : 243 - 244
  • [36] PREDICTING GLOBAL FUND GRANT DISBURSEMENTS FOR PROCUREMENT OF ARTEMISININ-BASED COMBINATION THERAPIES
    Cohen, Justin M.
    Singh, Inder
    O'Brien, Meg E.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 60 - 61
  • [37] Policy brief on improving access to artemisinin-based combination therapies for malaria in Mozambique
    Mbofana, Francisco
    Machatine, Gertrudes
    Moreira, Celeste
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (02) : 250 - 254
  • [38] Resistance to artemisinin-based combination therapy
    Breman, Joel G.
    LANCET INFECTIOUS DISEASES, 2012, 12 (11): : 820 - 822
  • [40] Access to artemisinin-based combination therapies and other anti-malarial drugs in Kinshasa
    Mandoko, P. Nkoli
    Sinou, V
    Mbongi, D. Moke
    Mumba, D. Ngoyi
    Mesia, G. Kahunu
    Likwela, J. Losimba
    Karhemere, S. Bi Shamamba
    Tshilolo, L. Muepu
    Muyembe, J-J Tamfum
    Parzy, D.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (04): : 269 - 277